Literature DB >> 2337683

Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40.

M L Randi1, F Fabris, A Girolami.   

Abstract

Over the past 13 years 57 cases of primary thrombocytosis in young people have been studied. Only patients with a platelet count over 500 x 10(9)/liter and a follow-up longer than 2 years were considered. Thrombocytosis in young people represents approximately 25% of total cases referred to our department during this period. The most common causes are essential thrombocythemia (20 cases) and secondary thrombocytosis (22 cases). The highest platelet counts are found in essential thrombocythemia patients. Most of our patients were discovered by a fortuitous hematological examination. In contrast, 5 out of the polycythemic patients were recognized after a thrombosis. The same was true for 2 out of 20 essential thrombocythemia subjects. Four subjects (2 essential thrombocythemia and 2 secondary thrombocytosis) were diagnosed after hemorrhages. The overall survival was very good except for leukemic patients and thrombocytosis secondary to neoplasms. Vascular complications after diagnosis were scarce: 2 polycythemia vera patients showed bleedings during antiaggregating therapy. None of our patients developed epithelial cancer, malignant lymphoma or myelofibrosis. Vascular traumata seem more frequent in polycythemia vera regardless of age. Therefore, it seems useful to treat polycythemic patients, while no therapy seems to be indicated in other forms of thrombocytosis.

Entities:  

Mesh:

Year:  1990        PMID: 2337683     DOI: 10.1007/bf01728790

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  Diagnosis and classification of the polycythemias.

Authors:  N I Berlin
Journal:  Semin Hematol       Date:  1975-10       Impact factor: 3.851

2.  The significance of thrombocytosis in old age.

Authors:  M L Randi; A Casonato; F Fabris; C Vio; A Girolami
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

3.  Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.

Authors:  S Murphy; D S Rosenthal; A Weinfeld; J Briere; G B Faguet; W H Knospe; S A Landaw; J Laszlo; A V Pisciotta; A P Tartaglia
Journal:  Cancer Treat Rep       Date:  1982-07

Review 4.  Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy.

Authors:  S M DiFino; N A Lachant; J J Kirshner; A J Gottlieb
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

5.  Arterial thrombosis in essential thrombocythemia.

Authors:  S Hussain; J M Schwartz; S A Friedman; S N Chua
Journal:  Am Heart J       Date:  1978-07       Impact factor: 4.749

6.  Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years.

Authors:  Y Najean; P Mugnier; C Dresch; J D Rain
Journal:  Br J Haematol       Date:  1987-11       Impact factor: 6.998

7.  Clinical significance of beta-thromboglobulin in patients with high platelet count.

Authors:  F Fabris; M L Randi; A Casonato; R Dal Bo Zanon; P Bonvicini; A Girolami
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

8.  Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis.

Authors:  H J Iland; J Laszlo; D C Case; S Murphy; T A Reichert; C Y Tso; L R Wasserman
Journal:  Am J Hematol       Date:  1987-06       Impact factor: 10.047

9.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Authors:  P D Berk; J D Goldberg; P B Donovan; S M Fruchtman; N I Berlin; L R Wasserman
Journal:  Semin Hematol       Date:  1986-04       Impact factor: 3.851

10.  Primary thrombocythemia in the young patient.

Authors:  H C Hoagland; M N Silverstein
Journal:  Mayo Clin Proc       Date:  1978-09       Impact factor: 7.616

View more
  3 in total

Review 1.  Primary thrombocythemia: diagnosis, clinical manifestations and management.

Authors:  P J van Genderen; J J Michiels
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

2.  Thrombocythemia and thrombosis of the adrenal vessels.

Authors:  B Barillari; B Shapiro; D Gasparini; M Rocco; A Barillari; S Buzzolo; E Moratti
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

3.  Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.

Authors:  A Wehmeier; I Daum; H Jamin; W Schneider
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.